1. Communication and publications
Rosemary de Sousa, February 2008

2. We aim to provide a high-quality and highly valued information service on the drugs phenomenon in Europe
We communicate the results of the EMCDDA’s monitoring and analytical work
We communicate this information to
policy-makers and their advisors
scientists and researchers
practitioners and drug professionals
the media and general public

3. How important is the EMCDDA's role in providing the information needed by policy-makers?
Source: External evaluation of the EMCDDA, 2007

4. Context of current developments
Communicating more effectively – priority in 2007–2009 strategy
Updated communication strategy (endorsed by Management Board in 2007)
External evaluation conclusions and recommendations
2008 work programme

5. Priorities for 2008
Draw up action plan that makes balanced use of existing communication channels
Improve link between communication activities and scientific work
Reassess each output to see how it is meeting audience needs
Improve turnaround time of outputs and meet minimum output targets
Strengthen image and reputation as ‘EMCDDA – your reference point on drugs in Europe’

6. Channels and tools used to communicate
Websites
Publications
Media relations and marketing
Participation in conferences
Events and representation work
Distribution

7. Overview of our publications
Manuals
Annual report
Drugnet
Risk assessments
Thematic papers
Insights
Monographs
Activities’ report
Drugs in focus
Selected issues

8. Annual report process

9. Drug situation online
Country data profiles
Drugnet Europe online
Statistical bulletin
Drug profiles
Selected issues

10. How do you rate the quality of the various EMCDDA publications and other information?
Source: External evaluation of the EMCDDA, 2007

11. Outputs due for release shortly
GHB and its precursor GBL: an emerging trend case study (Thematic paper)
Substance use among older adults: a neglected problem (Drugs in focus)
A cannabis reader: global issues and local experiences. Perspectives on cannabis controversies, treatment and regulation in Europe (Monograph)
Prevention of substance abuse (Insights)
Best practice portal
General report of activities 2007

12. Outputs due for release before the summer
Key indicator gateway
Drug use, impaired driving and traffic accidents (Insights)
Assessing illicit drugs in wastewater – prospects for a new approach to monitoring drug use in the community (Insights)
Heroin trafficking (Drugs in focus)
Public expenditure (Selected issue)
Drug profiles: hallucinogenic mushrooms, LSD, ketamine, GHB, volatile substances
Statistical bulletin
Country situation summaries